YD Bio YDES
NASDAQ YDES
$6.18 +0.06 (+0.98%)
As of: Oct 20, 2026 · 12:57 PM EDT

YD Bio (YDES) Common Equity (2024 - 2026)

Updated

YD Bio (YDES) recorded Common Equity of $4.47 million in the quarter ended Jun 30, 2026, down 12.1% from $5.09 million a year earlier.

Analysis

YD Bio (YDES) Common Equity (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, YD Bio reported Common Equity of -$2.86 million.

  • Across earlier years, Common Equity came in at $6.59 million in the year ended Dec 31, 2024 and $22,994 in the year ended Dec 31, 2023.
  • Quarterly Common Equity has ranged from -$2.86 million in the quarter ended Dec 31, 2025 to $6.59 million in the quarter ended Dec 31, 2024 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,152.93 Bn 1,121.51 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 623.85 Bn 542.38 Bn 17.26 Bn 84.97 Bn
3 AbbVie 512.32 Bn 485.43 Bn 12.70 Bn -5.94 Bn
4 Merck 365.51 Bn 319.89 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 297.25 Bn 261.24 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 261.29 Bn 234.98 Bn 12.86 Bn 50.37 Bn
7 Amgen 234.60 Bn 190.00 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 192.87 Bn 167.07 Bn 6.22 Bn 11.83 Bn
9 Pfizer 171.71 Bn 118.36 Bn 10.94 Bn 85.49 Bn
10 YD Bio 412.32 Mn 400.05 Mn - 4.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.47 Mn
Dec 31, 2025 -2.86 Mn
Jun 30, 2025 5.09 Mn
Dec 31, 2024 6.59 Mn
API Access

YD Bio Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=YDES&period=max&api_key=YOUR_API_KEY